Brief: Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
08/11/2021 13:28
Nov 8 (Reuters) - Amyris Inc AMRS.O :
* AMYRIS ANNOUNCES JV PARTNERSHIP WITH IMMUNITYBIO FOR NEXT
GENERATION COVID-19 RNA VACCINE
* AMYRIS - ENTERED INTO A 50:50 JOINT VENTURE ARRANGEMENT
WITH
IMMUNITYBIO TO ACCELERATE COMMERCIALIZATION OF A LEADING
NEXT-GENERATION COVID-19 VACCINE
Source text for Eikon: ID:nPn76tnNBa
Further company coverage: AMRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amyris
See all newsBrief: Amyris Announces Kathy Fortmann As New CEO
Brief: Amyris Announced Termination Or Separation Of About 80 Employees on Feb 7
Brief: Amyris- Related To Sale Of Some Consumer Brands, Announces Termination/ Separation Of About 220 Employees
Brief: Amyris On December 12, Debtors Entered Into An Amendment To And Restatement Of That Certain Plan Support Agreement, Dated October 12, 2023
Brief: Amyris Inc On August 10, Received Notice Of Delisting From Nasdaq